Mu-opioid receptor heterooligomer formation with the dopamine D1 receptor as directly visualized in living cells
about
Pharmacology of signaling induced by dopamine D(1)-like receptor activationA dopamine D1 receptor-dependent β-arrestin signaling complex potentially regulates morphine-induced psychomotor activation but not reward in mice.In vivo opioid receptor heteromerization: where do we stand?Biological Significance of GPCR Heteromerization in the Neuro-Endocrine SystemCocaine withdrawal-induced trafficking of delta-opioid receptors in rat nucleus accumbensDopamine D1 receptor antagonism in the prelimbic cortex blocks the reinstatement of heroin-seeking in an animal model of relapse.Blockade of neuronal dopamine D2 receptor attenuates morphine tolerance in mice spinal cord.Heterodimerisation of G protein-coupled receptors: implications for drug design and ligand screening.Dopamine and renal function and blood pressure regulation.Neurochemical evidence supporting dopamine D1-D2 receptor heteromers in the striatum of the long-tailed macaque: changes following dopaminergic manipulationInteractive effects of morphine and dopaminergic compounds on spatial working memory in rhesus monkeys.Dopamine D₄ receptor counteracts morphine-induced changes in µ opioid receptor signaling in the striosomes of the rat caudate putamen.Extrasynaptic neurotransmission in the modulation of brain function. Focus on the striatal neuronal-glial networks.Dopamine D1 and corticotrophin-releasing hormone type-2α receptors assemble into functionally interacting complexes in living cells.Heteromers of μ opioid and dopamine D1 receptors modulate opioid-induced locomotor sensitization in a dopamine-independent manner.G protein-coupled receptor oligomerization for what?Making Sense of Rodent Models of Anhedonia
P2860
Q34126949-EBE8739F-45D8-45A3-9773-F689376000B1Q34490940-D9562DB7-3EF0-4B24-BBAE-16340BFA53BBQ34939677-03326F9E-048C-45A6-BB6B-0C930EAD508CQ35971498-8260162E-F573-427E-A978-76757A821FBFQ36776058-A49962DF-DF9C-447B-9E73-2512BB19585FQ37353762-A7BB3646-4632-4566-9D75-E036DEC6BEC5Q37526133-26F202E6-7879-4FB5-9E59-33626459B936Q38028547-8897A000-307B-49FF-AEA0-089234EFD969Q38111703-E7CFFBD3-115A-464C-A4DB-5AB43FE73B66Q39405720-E81DEE6F-00C8-438E-A8C1-FDBD93F10174Q41453004-F32E2368-ECB3-4726-A108-44DFAEB76CAEQ41902104-4169BC6A-39A9-4F54-BBC1-4337DBCEE648Q42050477-C5B142D6-1398-448B-B45D-52A619BE7EB3Q43101490-3D2D9A6A-955C-479E-8D8A-755D644ADF75Q44346471-9D2A1038-080A-4046-B373-0FB9553FE808Q57781319-41A74088-F0FE-48B3-A4FD-9EDD61EBA898Q58708889-3A034215-116A-4A1B-99FC-F73770B69131
P2860
Mu-opioid receptor heterooligomer formation with the dopamine D1 receptor as directly visualized in living cells
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Mu-opioid receptor heterooligo ...... tly visualized in living cells
@ast
Mu-opioid receptor heterooligo ...... tly visualized in living cells
@en
Mu-opioid receptor heterooligo ...... tly visualized in living cells
@nl
type
label
Mu-opioid receptor heterooligo ...... tly visualized in living cells
@ast
Mu-opioid receptor heterooligo ...... tly visualized in living cells
@en
Mu-opioid receptor heterooligo ...... tly visualized in living cells
@nl
prefLabel
Mu-opioid receptor heterooligo ...... tly visualized in living cells
@ast
Mu-opioid receptor heterooligo ...... tly visualized in living cells
@en
Mu-opioid receptor heterooligo ...... tly visualized in living cells
@nl
P2093
P921
P1476
Mu-opioid receptor heterooligo ...... tly visualized in living cells
@en
P2093
Ahmed Hasbi
Asim J Rashid
Brian F O'Dowd
Christopher H So
Jason R Juhasz
Susan R George
P304
P356
10.1016/J.EJPHAR.2007.11.060
P407
P577
2008-03-10T00:00:00Z